TC
PGEN icon

Truvestments Capital’s Precigen PGEN Stock Holding History

Truvestments Capital’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29K Hold
578
– – ﹤0.01% 963
2026
Q1 		$2.24K Hold
578
– – ﹤0.01% 997
2025
Q4 		$2.42K Hold
578
– – ﹤0.01% 875
2025
Q3 		$1.9K Hold
578
– – ﹤0.01% 924
2025
Q2 		$821 Hold
578
– – ﹤0.01% 887
2025
Q1 		$861 Sell
578
-800
-58% -$1.26K ﹤0.01% 936
2024
Q4 		$1.54K Buy
1,378
+800
+138% +$682 ﹤0.01% 880
2024
Q3 		$547 Buy
+578
New +$729 ﹤0.01% 871
2024
Q2 		– Sell
-1,578
Closed -$2.29K – 546
2024
Q1 		$2.29K Sell
1,578
-1,000
-39% -$1.44K ﹤0.01% 612
2023
Q4 		$3.46K Hold
2,578
– – ﹤0.01% 637
2023
Q3 		$3.66K Hold
2,578
– – ﹤0.01% 544
2023
Q2 		$2.96K Sell
2,578
-1,000
-28% -$1.18K ﹤0.01% 574
2023
Q1 		$3.79K Sell
3,578
-500
-12% -$721 ﹤0.01% 535
2022
Q4 		$6.2K Buy
4,078
+72
+2% +$124 ﹤0.01% 518
2022
Q3 		$8K Sell
4,006
-300
-7% -$633 0.01% 434
2022
Q2 		$6K Buy
+4,306
New +$6.39K ﹤0.01% 467
2022
Q1 		– Sell
-4,306
Closed -$16K – 438
2021
Q4 		$16K Sell
4,306
-300
-7% -$1.29K 0.01% 364
2021
Q3 		$23K Hold
4,606
– – 0.01% 308
2021
Q2 		$30K Hold
4,606
– – 0.02% 287
2021
Q1 		$32K Buy
4,606
+246
+6% +$2.08K 0.02% 325
2020
Q4 		$44K Buy
+4,360
New +$28.3K 0.03% 280
2020
Q2 		– Sell
-4,600
Closed -$15K – 609
2020
Q1 		$15K Buy
+4,600
New +$19.9K 0.02% 297
2019
Q4 		– Sell
-5,357
Closed -$31K – 453
2019
Q3 		$31K Sell
5,357
-42
-0.8% -$285 0.02% 342
2019
Q2 		$41K Sell
5,399
-700
-11% -$3.77K 0.03% 307
2019
Q1 		$32K Buy
+6,099
New +$42.3K 0.02% 337
2018
Q3 		$94K Buy
+5,468
New +$81.3K 0.05% 265

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Truvestments Capital's PGEN Position: Q2 2026 in Review

Truvestments Capital held its Precigen (PGEN) position steady in Q2 2026 at 578 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Truvestments Capital first reported a position in PGEN in Q3 2018 and has held it in 26 quarters since. The position peaked at $94K in Q3 2018. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Truvestments Capital held 578 shares of Precigen worth $3.29K as of Q2 2026.
  • Truvestments Capital left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #963 holding.
  • Truvestments Capital first reported a position in Precigen in Q3 2018 and has held it in 26 quarters since.
  • Truvestments Capital's Precigen position peaked at $94K in Q3 2018.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.